National Human Genome Research Institute; Notice of Meetings, 2735-2736 [2012-890]

Download as PDF Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices effectiveness of a state-of-the-art software application for smart phones (i.e., mobile application), ‘‘Solar Cell.’’ This software application supports decision-making related to sun protection and exposure by Americans to reduce the risk of developing skin cancer attributable to chronic and severe UV exposure and developing other cancers attributable to vitamin D deficiency. The Solar Cell mobile smart phone application combines personal and behavior data with geo-spatial data (i.e., UV Index forecast, time, and location) and delivers actionable sun protection advice to reduce risk of skin cancer. Frequency of Response: Once. Affected Public: Individuals. Type of 2735 Respondents: Adults (18 and over) from the U.S. population who own Android smart phones. The annual reporting burden is estimated at 673 (see Table below). There are no Capital Costs, Operating Costs, and/or Maintenance Costs to report. A.12–1—ESTIMATES OF ANNUAL BURDEN HOURS Number of respondents Type of respondents Instrument Adults .................................... Screener (Appendix G) ......... Pre-test (Appendix A) ........... Post-test (Appendix B) ......... 1,875 245 184 Totals ............................. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Patricia Weber, DrPH, Program Director, NCI/NIH, SBIR Development Center, 6116 Executive Blvd., Suite 402, Rockville, MD 20852 or call non-toll-free number (301) 594– 8106 or email your request, including your address to: weberpa@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. mstockstill on DSK4VPTVN1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Dated: January 11, 2012. Vivian Horovitch-Kelley, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2012–872 Filed 1–18–12; 8:45 am] BILLING CODE 4140–01–P 16:21 Jan 18, 2012 1 1 1 15/60 (0.25) 20/60 (0.33) 40/60 (0.66) 2,304 Request for Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. VerDate Mar<15>2010 Average time per response (minutes/hour) Frequency of response Jkt 226001 National Institutes of Health National Human Genome Research Institute; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Council for Human Genome Research. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Human Genome Research. Date: February 13–14, 2012. Open: February 13, 2012, 8:30 a.m. to 3 p.m. Agenda: To discuss matters of program relevance. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Frm 00052 Fmt 4703 Sfmt 4703 469 82 123 673 DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 Annual burden hours Closed: February 13, 2012, 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 5635 Fishers Lane Terrace Level Conference Room, Rockville, MD 20892. Closed: February 14, 2012, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Contact Person: Mark S. Guyer, Ph.D., Director for Extramural Research National Human Genome Research Institute, 5635 Fishers Lane, Suite 4076, MSC 9305, Bethesda, MD 20892, (301) 496–7531 guyerm@mail.nih.gov. Name of Committee: National Advisory Council for Human Genome Research. Date: May 21–22, 2012. Open: May 21, 2012, 8:30 a.m. to 3 p.m. Agenda: To discuss matters of program relevance. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Closed: May 21, 2012, 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Closed:May 22, 2012, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Contact Person: Mark S. Guyer, Ph.D., Director for Extramural Research, National Human Genome Research Institute, 5635 Fishers Lane, Suite 4076, MSC 9305, Bethesda, MD 20892, (301) 496–7531, guyerm@mail.nih.gov. Name of Committee: National Advisory Council for Human Genome Research. Date: September 10–11, 2012. Open: September 10, 2012, 8:30 a.m. to 3 p.m. E:\FR\FM\19JAN1.SGM 19JAN1 2736 Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices Agenda: To discuss matters of program relevance. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Closed: September 10, 2012, 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Closed: September 11, 2012, 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Room, Rockville, MD 20892. Contact Person: Mark S. Guyer, Ph.D., Director for Extramural Research, National Human Genome Research Institute, 5635 Fishers Lane, Suite 4076, MSC 9305, Bethesda, MD 20892, (301) 496–7531, guyerm@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.genome.gov/11509849, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: January 11, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–890 Filed 1–18–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which VerDate Mar<15>2010 16:21 Jan 18, 2012 Jkt 226001 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Planning and Implementation. Date: February 6–7, 2012. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications, Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities/ NIAID, National Institutes of Health, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 451–2634, james.snyder@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 11, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–885 Filed 1–18–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group; Microbiology and Infectious Diseases B Subcommittee. Date: February 8–9, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Nancy Lewis Ernst, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 451–7383, nancy.ernst@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 11, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–884 Filed 1–18–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and thediscussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement (U01). Date: February 7–8, 2012. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, DHHS/NIH/NIAID, 6700B Rockledge Drive, MSC 7616, Room # 3257, Bethesda, MD 20892, (301) 435–1614, james.snyder@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\19JAN1.SGM 19JAN1

Agencies

[Federal Register Volume 77, Number 12 (Thursday, January 19, 2012)]
[Notices]
[Pages 2735-2736]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-890]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Advisory Council for Human Genome Research.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Human Genome 
Research.
    Date: February 13-14, 2012.
    Open: February 13, 2012, 8:30 a.m. to 3 p.m.
    Agenda: To discuss matters of program relevance.
    Place: National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Closed: February 13, 2012, 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, 5635 Fishers Lane Terrace 
Level Conference Room, Rockville, MD 20892.
    Closed: February 14, 2012, 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Contact Person: Mark S. Guyer, Ph.D., Director for Extramural 
Research National Human Genome Research Institute, 5635 Fishers 
Lane, Suite 4076, MSC 9305, Bethesda, MD 20892, (301) 496-7531 
guyerm@mail.nih.gov.

    Name of Committee: National Advisory Council for Human Genome 
Research.
    Date: May 21-22, 2012.
    Open: May 21, 2012, 8:30 a.m. to 3 p.m.
    Agenda: To discuss matters of program relevance.
    Place: National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Closed: May 21, 2012, 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Closed:May 22, 2012, 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Contact Person: Mark S. Guyer, Ph.D., Director for Extramural 
Research, National Human Genome Research Institute, 5635 Fishers 
Lane, Suite 4076, MSC 9305, Bethesda, MD 20892, (301) 496-7531, 
guyerm@mail.nih.gov.

    Name of Committee: National Advisory Council for Human Genome 
Research.
    Date: September 10-11, 2012.
    Open: September 10, 2012, 8:30 a.m. to 3 p.m.

[[Page 2736]]

    Agenda: To discuss matters of program relevance.
    Place: National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Closed: September 10, 2012, 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Closed: September 11, 2012, 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, 5635 Fishers Lane, Terrace 
Level Conference Room, Rockville, MD 20892.
    Contact Person: Mark S. Guyer, Ph.D., Director for Extramural 
Research, National Human Genome Research Institute, 5635 Fishers 
Lane, Suite 4076, MSC 9305, Bethesda, MD 20892, (301) 496-7531, 
guyerm@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.genome.gov/11509849, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: January 11, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-890 Filed 1-18-12; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.